However, I do not believe that DexCom is dead money. For example, during the September ... Using the FactSet data in the chart below, this year, analysts expect 13% EPS growth - down from 15% ...

shows whether a company's incremental sales were profitable – for example, revenue could be inflated through excessive spending on advertising and promotions. DexCom’s EPS grew at an ...

This Zacks Rank #2 (Buy) company’s shares have gained 10.1% year to date compared to the industry’s 8.8% decline. The S&P 500 Index has declined 0.4% in the same time frame. DXCM, a renowned ...

DexCom recently received a warning letter from the FDA, which pointed out issues in manufacturing processes and quality management. While these regulatory developments did not impact its ability ...

SAN FRANCISCO—After spending the past year extending its portfolio of continuous glucose monitors to include people who may not have diabetes, Dexcom said it expects to see more than $4.03 ...

By Bhanvi Satija (Reuters) -Dexcom shares closed more than 40% lower on Friday after the glucose monitor maker slashed its annual revenue forecast due to the fallout from a salesforce revamp ...

Is the Ozempic craze dinging makers of diabetes devices? Shares of DexCom, which makes monitoring devices for diabetes patients, tumbled 40% in early trading after it cut sales guidance.